Ledesma-Heyer JP, Valdés-Escárcega M, Ramos-Ostos MH

Idioma: Español
Referencias bibliográficas: 46
Paginas: 168-173
Archivo PDF: 81.29 Kb.

RESUMEN

La inmunosenescencia es un tipo de inmunodeficiencia adquirida idiopática resultado de cambios celulares y moleculares propios del envejecimiento. En el presente artículo se revisarán los principales cambios a nivel del timo y de las respuestas innata y adquirida de la inmunidad. Asimismo, se comentarán algunas teorías del envejecimiento inmunológico. Diversas enfermedades propias de la vejez (infecciones, cáncer, crónico-degenerativas, osteoporosis, etc.) tienen su origen en el sistema inmune envejecido.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Fillit H. Clinical immunology of aging. Rev Clin Gerontol 1994; 4: 187-97.

2. Iglesias M. Inmunosenescencia y autoinmunidad. Reumatología 2003; 19(2): 61-7.

3. Burkle A, Caselli G, Franceschi C, et al. Pathophysiology of ageing, longevity and age related diseases. Immun Ageing 2007; 4: 4.

4. Ginaldi L, Mengoli LP, DeMartinis M. Review on immunosenescence. Rev Clin Gerontol 2007; 17: 161-9.

5. Rider D, Young S. A radical view of immunosenescence: Does chronic redox depletion interfere with immune cell signaling and function? Rev Clin Gerontol 2000; 10: 5-15.

6. Yu BP, Chung HY. The inflammatory process in aging. Rev Clin Gerontol 2006; 16: 179-87.

7. Vasto S, Malavolta M, Pawelec G. Age and immunity. Immun Ageing 2006; 3: 2.

8. Solana R, Pawelec G, Tarazona R. Aging and innate immunity. Immunity 2006; 24: 491-6.

9. Licastro F, Candore G, Lio D, et al. Innate immunity and inflammation in ageing: a key for understanding age-related diseases. Immun Ageing 2005; 2: 8.

10. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflamm-aging and lifelong antigenic load as major determinants of ageing rate and longevity. FEBS 2005; 579: 2035-9.

11. Derhovanessian E, Solana R, Larbi A, Pawelec G. Immunity, ageing and cancer. Immun Ageing 2008; 5: 11.

12. Boren E, Gershwin E. Inflamm-ageing: autoimmunity, and the immune-risk phenotype. Autoimmunity Reviews 2004; 3: 401-6.

13. Remarque E, Pawelec G. T-cell immunosenescence and its clinical relevance in man. Rev Clin Gerontol 1998; 8: 5-14.

14. Chung HY, Kim HJ, Jung KJ, et al. The inflammatory process in aging. Rev Clin Gerontol 2000; 10: 207-22.

15. Yung RL. Changes in immune function with age. Rheum Dis Clin North Am 2000; 3: 455-73.

16. Linton PJ, Dorshkind K. Age-related changes in lymphocyte development and function. Nat Immunol 2004; 5(2): 133-9.

17. Tortorella C, Pisconti A, Piazolla G, Antonaci S. APC-dependent impairment of T-cell proliferation in aging:role of the CD28-and IL-12/15 medicated signaling. Mech Ageing Dev 2002; 123: 1389-402.

18. Effros R. Roy Walford and the immunologic theory of aging. Immun Ageing 2005; 2: 7.

19. Kennes B, Hubert C, Brohee D, Neve P. Early biochemical events associated with lymphocyte activation in aging. I. Evidence that Ca2+-dependent processes induced by PHA are impaired. Immunology 1981; 42: 119-26.

20. Blackburn EH. Structure and function of telomeres. Nature 1991; 350: 569-72.

21. Giradon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients. A randomized controlled trial. Arch Intern Med 1999; 159: 748-54.

22. Vasto S, Candore G, Balistreri CR, et al. Inflammatory networks in ageing, age-related diseases and longevity. Mech Ageing Dev 2007; 128: 83-91.

23. Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immun 2008; 9(5): 503-10.

24. Hadrup SR, Kollgard T, Saremet T, et al. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J Immunol 2006; 176: 2645-53.

25. De Martinis M, Franceschi C, Monti D, Ginaldi L. Inflammation markers predicting frailty and mortality in the elderly. Exp Mol Pathol 2006; 80: 219-27.

26. Bruunsgaard H, Andersen-Ramberg K, Jeune B, et al. A high plasma concentration of TNF-á is associated with dementia in centenarians. J Gerontol 1999; 54: 357-64.

27. Pawelec G, Larbi A. Immunity and ageing in man: Annual Review 2006/2007. Exp Gerontol 2008; 43: 34-8.

28. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of fas (CD95), fas ligand, bcl- 2, and bax. J Immunol 1998; 160: 1627-37.

29. LeMaoult J, Szabo P, Weksler ME. Effect of age on humoral immunity, selection of the B-cell repertoire and b-cell development. Immunol Rev 1997; 160: 115-26.

30. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998; 78: 547-81.

31. Aukrust P, Svardal AM, Muller F, et al. Increased levels of oxidized glutathione in CD4(+) lymphocytes associated with disturbed intracellular redox balance in human immunodeficiency virus type-1 infection. Blood 1995; 86: 258-67.

32. Hanson PM. Dampening inflammation. Nat Immunol 2005; 6: 1189-81.

33. Yu BP, Yang R. Critical evaluation of free radical theory of aging: a proposal of oxidative stress hypothesis. Ann NY Acad Sci 1996; 786: 1-11.

34. Franceschi C, Bonafe M. Centenarians as a model for healthy aging. Biochem Soc Trans 2003; 2: 457-61.

35. Licastro F, Grimaldi LME, Bonafe M, et al. Interleukin-6 gene alleles affect the risk of Alzheimer´s disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003; 24: 921-6.

36. Hayden M, Ghosh S. Shared principles in NK-kB signaling. Cell 2008; 132: 344-62.

37. Poon HF, Calabrese V, Scapagnini G, Butterfield A. Free radicals: key to brain aging and heme oxygenase as a cellular response to oxidative stress. J Gerontol A Biol Sci Med Sci 2004; 59(5): 478-93.

38. Zingarelli B. Nuclear factor-kB. Crit Care Med 2005; 33(12): S414-S416.

39. Gupta S. Tumor necrosis factor-A-induced apoptosis in T cells from aged humans; a role of TNFR-I and downstream signaling molecules. Exp Gerontol 2002; 37: 293-99.

40. Kim HJ, Jung KJ, Yu BP, et al. Modulation of redox-sensitive transcription factors by calorie restriction during aging. Mech Ageing Dev 2002; 123: 1589-95.

41. Yu BP. Aging and oxidative stress: modulation by dietary restriction. Free Rad Biol Med 1996; 21: 651-68.

42. Sung BK, Park S, Yu BP, Chung HY. Amelioration of age-related inflammation and oxidative stress by PPARγ activator: suppression of NF-κΒ by 2,4-thiazolidinedione. Exp Geront 2006; 41: 590-9.

43. Wikby A, Ferguson F, Forsey R, et al. An immune risk phenotype, cognitive impairment, and survival in very late life: impact of allostatic load in Swedish octogenarian and nonagenarian humans. J Gerontol A Biol Sci Med Sci 2005; 60: 556-65.

44. Henson SM, Snelgrove R, Hussell T, et al. An IL-7 fusion protein that shows increased thymopoietic ability. J Immunol 2005; 15(175): 4112-8.

45. Solana R, Mariani E. NK and NK/T cells in human senescence. Vaccine 2000; 18: 1613-20.

46. Ginaldi L, De Martinis M, Modesti M, et al. Immunophenotypical changes of T lymphocytes in the elderly. Gerontology 2000; 46: 242-8.